Dairy products are best vessel for probiotics, study says | Survey finds many people cannot define gluten | Pills' appearances color patients' expectations, study finds
 
July 24, 2015
CONNECT WITH ACG®  FacebookTwitter
Digestive Health SmartBrief
From Stanley K. Fergus and the American College of Gastroenterology
SIGN UP|FORWARD|ADVERTISE

Top Story
Dairy products are best vessel for probiotics, study says
Dairy products are the most effective vessel for administering probiotics, according to a study by the American Society for Microbiology. The study found that probiotics in milk decreased the symptoms of colitis in mice, compared with no probiotics or probiotics given in a nonfood supplement. Examiner.com (7/19)
Share: LinkedInTwitterFacebookGoogle+Email
What Can You Learn from an Accelerator?
Imagine what it would be like to take a fresh look at your small business, to think and act like it was a startup all over again. What would you change? What could you do better? What time- and money-wasting bad habits could you stop? Click here to read Boomtown: Think Like a Startup
Advertisement

Guide to Healthy Living
Survey finds many people cannot define gluten
A survey from NSF International found 90% of people had heard about gluten sensitivity or a gluten-free diet but 54% could not correctly define the term. Some common misunderstandings about gluten are that wheat-free products are gluten-free and that all grains contain gluten. Time.com (7/21)
Share: LinkedInTwitterFacebookGoogle+Email
Pills' appearances color patients' expectations, study finds
Patients in the U.S., China and Colombia estimate a pill's effectiveness and ease of use based on its color and shape, according to study data. Study participants viewed white pills as most effective for headaches and rated red and blue pills as harder to swallow. The Wall Street Journal (tiered subscription model) (7/20)
Share: LinkedInTwitterFacebookGoogle+Email
Many diabetes patients don't get recommended vaccines
Researchers found extensive nonadherence to national guidelines for hepatitis B, influenza and 23-valent pneumococcal polysaccharide vaccines among diabetes patients, who are considered to be at risk for infection and infectious disease complications. "Allocation of health care resources to increase vaccine coverage should remain a priority, with a focus on spreading awareness of the hepatitis B vaccine recommendation for people with diabetes," researchers said. PhysiciansBriefing.com/HealthDay News/ (7/20)
Share: LinkedInTwitterFacebookGoogle+Email
Diagnosis & Treatment
Weight-loss surgery may raise risk of reduced bone density, study says
A study by Cleveland Clinic researchers found that obese patients with type 2 diabetes who underwent gastric bypass or sleeve gastrectomy were at higher risk for reduced bone mineral content and bone mineral density, compared with patients who had medical treatment but not weight-loss surgery. The study linked BMD reductions to weight loss and changes in lean mass and leptin. Healio (free registration)/Endocrine Today (7/20)
Share: LinkedInTwitterFacebookGoogle+Email
Clinical trial results reported for hepatitis D treatment
A Phase IIa clinical study by NIH researchers found that a 28-day regimen of lonafarnib was associated with dose-dependent reductions in viral load among patients with hepatitis D. Gastrointestinal side effects were the most common adverse events. European Pharmaceutical Review (U.K.) (7/20)
Share: LinkedInTwitterFacebookGoogle+Email
Policy Watch
Study: State regulations may have role in late diagnoses for colorectal cancer
State regulations governing clinicians and health insurance may be a factor in the prevalence of late diagnoses for colorectal cancer patients under age 65, according to a study from Georgia State University and the University of North Carolina. Researchers analyzed the link between late diagnoses and state regulations and guidelines for cancer screening that affect clinical recommendations and insurance coverage. United Press International (7/20)
Share: LinkedInTwitterFacebookGoogle+Email
Measure to use telehealth to boost care access of Medicare patients
A measure proposed by Reps. Devin Nunes, R-Calif., and Frank Pallone Jr., D-N.J., would open the door for Medicare clinicians to offer telehealth care across state lines. The Telemedicine for Medicare, or Telemed Act, is intended to address the need for more clinicians while increasing access to care by Medicare patients in underserved areas. Health Data Management (7/20)
Share: LinkedInTwitterFacebookGoogle+Email
Patient's Perspective
Dealing with the reality of IBD
"'Just think about it Ris. By this time tomorrow you would be all finished with the hard stuff. You’ll relax then get back to swimming and move on from whatever this was.' My dad said those words to me on the eve of my IBD diagnosis ... It just goes to show you that many of us really do have the mentality of 'this can’t really happen to me or someone I love. It is sad it happens to other people though.' ... I miss the innocence, I miss the fact that my dad legitimately meant what he said and we all believed it." -- blog post from Marisa on JournalingIBD.org
Share: LinkedInTwitterFacebookGoogle+Email
The Last Word
News and information from the American College of Gastroenterology
Foodborne illnesses: Protect your gut
At some point in our lives, we've all gotten sick from eating contaminated or undercooked food. You can reduce your risk of developing foodborne illnesses by following a few safety tips. Learn more about the common types of foodborne illnesses and what you can do to protect your gut.
Share: LinkedInTwitterFacebookGoogle+Email
SmartQuote
Success depends upon previous preparation, and without such preparation there is sure to be failure."
-- Confucius,
philosopher and teacher
Share: LinkedInTwitterFacebookGoogle+Email
Contact Your Doctor
Stanley K. Fergus
Gastroenterolgy Associates of West Tennessee
1400 Kings Boulevard
Memphis, TN 38105

Phone: (901) 555-1234
 
Contact ACG
American College of Gastroenterology
P.O. Box 342260
Bethesda, MD 20827-2260
The presence of any advertisement in this newsletter does not constitute endorsement of the associated service, product, or company by the American College of Gastroenterology, SmartBrief, or any participating physicians.
The information contained in Digestive Health SmartBrief is not intended to be medical advice. Consult your physician before making any decisions regarding your health care.
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Tara Rosenzweig
Advertising:  Rebecca Adelson
  P: 202.618.5665
 
 

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information